Nicotinamide Inhibits IRF-1 mRNA Induction and Prevents IL-1β-Induced Nitric Oxide Synthase Expression in Pancreatic β Cells

Atsuya Akabane, Ichiro Kato, Shin Takasawa, Michiaki Unno, Hideto Yonekura, Takashi Yoshimoto, Hiroshi Okamoto

研究成果: Article査読

31 被引用数 (Scopus)

抄録

Nitric oxide produced by inducible nitric oxide synthase in islets exerts inhibitory and cytotoxic effects on pancreatic β cells and is therefore thought to be a potent mediator in the pathogenesis of Type I diabetes mellitus. Here, using isolated rat pancreatic islets, we show that high-concentration nicotinamide (20 mM), but not low-concentration nicotinamide (5 mM) attenuates the interleukin-1β-evoked inhibition of glucose-induced insulin secretion by preventing the induction of interferon regulatory factor-1, a transcriptional factor which plays an essential role in inducible nitric oxide synthase gene expression, and the interleukin-1β-induced nitric oxide formation. High-concentration nicotinamide also restored an interleukin-1β-induced decrease in ATP content in pancreatic β cells, suggesting that interleukin-1β-induced nitric oxide inhibits the mitochondrial function. The present results show the molecular basis of the preventive effect of high-dose nicotinamide on Type I diabetes mellitus.

本文言語English
ページ(範囲)524-530
ページ数7
ジャーナルBiochemical and biophysical research communications
215
2
DOI
出版ステータスPublished - 1995

ASJC Scopus subject areas

  • 生物理学
  • 生化学
  • 分子生物学
  • 細胞生物学

フィンガープリント

「Nicotinamide Inhibits IRF-1 mRNA Induction and Prevents IL-1β-Induced Nitric Oxide Synthase Expression in Pancreatic β Cells」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル